In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Racial disparities in breast cancer may have genetic factor - STAT

Treatment Efficacy Score a Better Way to Predict Long-Term

Frontiers Racial Disparity and Social Determinants in Receiving

Tumor biology predicts breast cancer treatment outcomes more than race

Routine Genetic Testing of Germline Breast Cancer Susceptibility

Races Differ in Breast Cancer Chemotherapy Response

Breast cancer Nature Reviews Disease Primers

BRCA1 – Inherited Cancer Registry (ICARE)

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

African-American Breast Cancer Patients Can Improve Their Outcomes

Breast cancer - Wikipedia

Disparities in Clinical Research and Cancer Treatment

The impact of race and ethnicity in breast cancer—disparities and